Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1624
    +0.0013 (+0.11%)
     

  • GBP/USD

    1.2526
    +0.0002 (+0.02%)
     

  • Bitcoin GBP

    48,144.38
    -1,265.06 (-2.56%)
     

  • CMC Crypto 200

    1,254.97
    -103.04 (-7.59%)
     

  • S&P 500

    5,217.51
    +3.43 (+0.07%)
     

  • DOW

    39,468.35
    +80.59 (+0.20%)
     

  • CRUDE OIL

    78.31
    -0.95 (-1.20%)
     

  • GOLD FUTURES

    2,375.50
    +35.20 (+1.50%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

FibroGen Inc (FGEN) Q4 2020 Earnings Call Transcript

Motley Fool Transcribers, The Motley Fool
·35-min read
FibroGen Inc (FGEN) Q4 2020 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen Fourth Quarter and Full Year 2020 Financial Results Conference Call. Joining me on today's are Enrique Conterno, our Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China Operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety, and Pharmacovigilance.

Continue reading